Ercem Atillasoy files SEC Form 4 disclosures for Allovir, Inc.. They have made 8 open-market trades across 1 company since 2020, most recently 2022-10-21.
CIK 0001818802
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $60K since 2020, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALVR | 132,899 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2022-10-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALVR | SELL | 2022-10-20 | 2022-10-26 | $8.72 | $18K | +11.1% | +5.6% | -21.9% |
| ALVR | SELL | 2022-10-19 | 2022-10-24 | $8.72 | $18K | -5.2% | +1.8% | -29.9% |
| ALVR | SELL | 2022-07-21 | 2022-07-22 | $5.38 | $8K | +17.4% | +45.3% | +73.5% |
| ALVR | SELL | 2022-07-20 | 2022-07-21 | $5.21 | $3K | +3.4% | +34.4% | +79.4% |
| ALVR | SELL | 2022-04-20 | 2022-04-22 | $6.04 | $12K | +12.0% | -9.5% | +21.5% |
| ALVR | SELL | 2022-01-25 | 2022-01-26 | $8.24 | $38K | +4.4% | +16.3% | -39.6% |
| ALVR | SELL | 2021-10-21 | 2021-10-25 | $24.23 | $37K | +0.4% | -23.1% | -66.3% |
| ALVR | BUY | 2020-08-03 | 2020-08-05 | $17.00 | $60K | +24.6% | -20.1% | -10.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.